POS0370. Type i interferon pathway assays in patients with rheumatic and musculoskeletal diseases - systematic literature review (slr) and development of consensus terminology from a eular taskforce

dc.contributor.author	Burska, A.
dc.contributor.author	Rodríguez Carrio, Javier
dc.contributor.author	Conaghan, P. G.
dc.contributor.author	Dik, W. A.
dc.date.accessioned	2022-06-29T08:16:11Z
dc.date.available	2022-06-29T08:16:11Z
dc.date.issued	2021
dc.identifier.issn	0003-4967
dc.identifier.issn	1468-2060
dc.identifier.uri	http://hdl.handle.net/10651/63567
dc.description	Poster
dc.description.statementofresponsibility	Burska, A., Rodríguez Carrio, J., Conaghan, P. G., Dik, W. A., Biesen, R., Elorana, M. L., Cavalli, G., Visser, M., Boumpas, D., Bertsias, G., Wahren-Herlenius, M., Rehwinkel, J., Frémond, M. L., Crow, M. K., Ronnblom, L., Vital, E., Versnel, M.
dc.format.extent	p. 415-415
dc.language.iso	eng
dc.relation.ispartof	Annals of the rheumatic diseases
dc.rights	© 2021, BMJ Publishing Group Ltd. & European League Against Rheumatism
dc.source	WOS:000692649600040
dc.title	POS0370. Type i interferon pathway assays in patients with rheumatic and musculoskeletal diseases - systematic literature review (slr) and development of consensus terminology from a eular taskforce
dc.type	conference output	spa
dc.identifier.doi	10.1136/annrheumdis-2021-eular.3788
dc.relation.publisherversion	http://dx.doi.org/10.1136/annrheumdis-2021-eular.3788

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.